Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 476
Gene Symbol: ATP1A1
ATP1A1
0.420 GeneticVariation phenotype BEFREE Dominant mutations in ATP1A1, encoding the alpha-1 isoform of the Na<sup>+</sup> /K<sup>+</sup> -ATPase, have been recently reported to cause an axonal to intermediate type of Charcot-Marie-Tooth disease (ie, CMT2DD) and a syndrome with hypomagnesemia, intractable seizures and severe intellectual disability. 31705535 2020
Entrez Id: 476
Gene Symbol: ATP1A1
ATP1A1
0.420 Biomarker phenotype GENOMICS_ENGLAND Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability. 30388404 2018
Entrez Id: 476
Gene Symbol: ATP1A1
ATP1A1
0.420 GeneticVariation phenotype BEFREE Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability. 30388404 2018
Entrez Id: 476
Gene Symbol: ATP1A1
ATP1A1
0.420 Biomarker phenotype HPO
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 Biomarker phenotype BEFREE Genetic disorders of CLDN16 cause mislocalization of CLDN16, resulting in hypomagnesemia. 31273276 2019
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations. 30621608 2019
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 Biomarker phenotype BEFREE Deletion of claudin-10 rescues claudin-16-deficient mice from hypomagnesemia and hypercalciuria. 29129401 2018
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE To better understand the role of the inward-rectifying K channel Kir4.1 (KCNJ10) in the distal nephron, we initially studied a global Kir4.1 knockout mouse (gKO), which demonstrated the hypokalemia and hypomagnesemia seen in SeSAME/EAST syndrome and was associated with reduced Na/Cl cotransporter (NCC) expression. 30110571 2018
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE Gitelman syndrome (GS) is an autosomal recessive disease characterized by hypokalemic metabolic alkalosis in combination with significant hypomagnesemia and hypocalciuria which is caused by mutations in the SLC12A3 gene. 26260218 2016
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family. 27067446 2016
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE Compared with those with CLCNKB mutations, patients with SLC12A3 mutations were characterized by more consistent hypocalciuria and hypomagnesemia. 26770037 2016
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE Loss of function of mutated solute carrier family 12 member 3 (SLC12A3) gene is the most frequent etiology for Gitelman syndrome (GS), which is mainly manifested by hypokalemia, hypomagnesemia and hypocalciuria. 27783806 2016
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is a rare autosomal recessive renal disease caused by mutations in genes for the tight junction transmembrane proteins Claudin-16 (CLDN16) and Claudin-19 (CLDN19). 25366522 2015
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE Seventeen GS patients with SLC12A3 gene mutations were enrolled, five of whom did not have a history of hypomagnesemia. 26121437 2015
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE The molecular mechanism by which gamma-Na(+)/K(+)-ATPase is involved in DCT Mg(2+) handling remains unknown; (v) a high percentage of patients with mutations in the renal transcription factor HNF1B (hepatocyte nuclear factor 1 homeobox B) gene develop hypomagnesemia; and (vi) Gitelman and EAST/SeSAME syndrome patients suffer from a similar tubulopathy due to mutations in NCC (NaCl cotransporter) and Kir4.1, respectively. 19812536 2010
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Dent's disease, an X-linked disorder characterized by low molecular weight proteinuria, hypercalciuria and nephrolithiasis, is due to mutations of the chloride/proton antiporter 5, CLC-5; ADHH is associated with activating mutations of the CaSR, which is a G-protein-coupled receptor; hypophosphatemic hypercalciuric nephrolithiasis associated with rickets is due to mutations in the type 2c sodium-phosphate co-transporter (NPT2c); and familial hypomagnesemia with hypercalciuria is due to mutations of paracellin-1, which is a member of the claudin family of membrane proteins that form the intercellular tight junction barrier in a variety of epithelia. 18446382 2009
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Mutations in claudin-16 have been identified in patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. 19538297 2009
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 Biomarker phenotype BEFREE Mutations in the claudin 16 (paracellin) paracellular protein in the thick ascending limb (TAL) of Henle's loop and in the transient receptor potential cation channel, subfamily 6, member 6 (TRPM6) magnesium channel expressed in distal tubules found in patients with renal magnesium wasting and hypomagnesemia underscore the importance of these transport proteins. 17918133 2007
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE A novel PCLN-1 gene mutation in familial hypomagnesemia with hypercalciuria and atypical phenotype. 17123117 2007
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Dent's disease, an X-linked disorder characterized by low molecular weight proteinuria, hypercalciuria, and nephrolithiasis, is due to mutations of the chloride/proton antiporter, CLC-5; ADHH is associated with activating mutations of the calcium-sensing receptor, which is a G protein-coupled receptor; hypophosphatemic hypercalciuric nephrolithiasis associated with rickets is due to mutations in the type 2c sodium-phosphate cotransporter (NPT2c); and familial hypomagnesemia with hypercalciuria is due to mutations of paracellin-1, which is a member of the claudin family of membrane proteins that form the intercellular tight junction barrier in a variety of epithelia. 17872384 2007
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.200 GeneticVariation phenotype BEFREE These results suggest that Gitelman syndrome requires 2 compound heterozygotic mutations and the coexistence of the large deletion in the C-terminal domain with Met672Ile substitution of the TSC could impair the transporter activity underling the hypokalemia and hypomagnesemia in this patient. 16429844 2006
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE The latter has been exemplified by the discovery of claudin 16 (paracellin-1) as the gene product responsible for the hypomagnesaemia with hypercalciuria syndrome. 16775457 2006
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE This case indicates the pathogenetic role of paracellin-1 mutation in familial hypomagnesemia with hypercalciuria and nephrocalcinosis and further underlines the risk of stone formation in heterozygous mutation carriers. 16804318 2006
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 AlteredExpression phenotype BEFREE Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface expression of a novel Claudin-16 mutant that lacks the entire C-terminal cytosolic tail. 16501001 2006
Entrez Id: 10686
Gene Symbol: CLDN16
CLDN16
0.200 GeneticVariation phenotype BEFREE Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations. 16047219 2005